1-17 of 17
Keywords: Venom immunotherapy
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Int Arch Allergy Immunol (2024) 185 (5): 456–459.
Published Online: 27 February 2024
...Sara López-Freire; Margarita Armisén; María Jesús Cruz; Carmen Vidal Introduction: Changes in the cytokine profile from type 2 to type 1 together with the induction of regulatory cells are expected during hymenoptera venom immunotherapy (VIT). The present study was aimed to investigate the changes...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Int Arch Allergy Immunol (2019) 180 (2): 128–134.
Published Online: 19 June 2019
...Yossi Rosman; Fatema Nashef; Anat Cohen-Engler; Keren Meir-Shafrir; Idit Lachover-Roth; Ronit Confino-Cohen Introduction: Venom immunotherapy (VIT) is considered to be the gold-standard treatment for patients with Hymenoptera venom allergy. Data regarding VIT in bee venom (BV) allergic patients...
Journal Articles
Journal Articles
Int Arch Allergy Immunol (2017) 174 (1): 45–51.
Published Online: 27 September 2017
...Yossi Rosman; Ronit Confino-Cohen; Arnon Goldberg Background: Venom immunotherapy (VIT) is considered to be the gold standard treatment for patients with hymenoptera venom allergy. This treatment induces systemic reactions (SR) in a significant number of patients. Objective: To evaluate the outcome...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Int Arch Allergy Immunol (2013) 160 (3): 313–321.
Published Online: 18 October 2012
... that accounts for nearly 20% of fatal anaphylaxis cases [ 1 ]. Fatalities are usually reported to occur in adults >45 years of age; however, children are also known to be at risk [ 2,3 ]. Systemic reactions Venom immunotherapy Bee allergy Children Hymenoptera venom anaphylaxis Insect venom...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Int Arch Allergy Immunol (2008) 146 (3): 248–254.
Published Online: 13 February 2008
...Andreja Peternelj; Mira Silar; Renato Erzen; Mitja Kosnik; Peter Korosec Background: Treatment failure of venom immunotherapy (VIT) is not rare and the risk and pathogenic factors for those failures are so far poorly understood. For that reason we evaluated allergen-specific basophil sensitivity...
Journal Articles
Int Arch Allergy Immunol (2001) 124 (4): 447–453.
Published Online: 27 April 2001
... of diagnostic tests is far from perfect and that both efficacy and tolerance, especially in patients receiving honeybee venom immunotherapy, are still suboptimal. The major allergens of honeybee and vespid venoms are now available in recombinant form. Preliminary trials analyzing diagnostic tests...
Journal Articles